| P2093 | author name string | Anne-Marie Heegaard | |
| | Camilla Kristine Appel | |
| | Brian Lee Schmidt | |
| | Chi Tonglien Viet | |
| | Nicole Newell Scheff | |
| P2860 | cites work | Bone cancer pain: from mechanism to therapy | Q27025262 |
| | Activation mechanism of endothelin ETB receptor by endothelin-1 | Q27727996 |
| | A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 |
| | GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells | Q28477278 |
| | Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma | Q28544907 |
| | Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury | Q28564446 |
| | CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 |
| | Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 |
| | Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain | Q30831131 |
| | Methylnaltrexone for opioid-induced constipation in advanced illness | Q33439945 |
| | Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer | Q33645099 |
| | Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice | Q33814735 |
| | Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain | Q34140692 |
| | Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. | Q34251507 |
| | Attenuation of activity in an endogenous analgesia circuit by ongoing pain in the rat | Q34267113 |
| | Malignant bone pain: pathophysiology and treatment | Q34418896 |
| | Peripheral mechanisms of opioid analgesia | Q34926296 |
| | Demethylating drugs as novel analgesics for cancer pain. | Q34959705 |
| | Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation | Q35041995 |
| | Evaluation of mammary gland development and function in mouse models | Q35379314 |
| | Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis | Q35790157 |
| | DNA Methylation Modulates Nociceptive Sensitization after Incision | Q35831786 |
| | Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain | Q36031497 |
| | Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation | Q36082658 |
| | Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer | Q36178615 |
| | Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo | Q36266756 |
| | Contribution of endoplasmic reticulum Ca2+ regulatory mechanisms to the inflammation-induced increase in the evoked Ca2+ transient in rat cutaneous dorsal root ganglion neurons | Q36900946 |
| | Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice | Q36923228 |
| | Spinal cord mechanisms of pain | Q37140262 |
| | Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice | Q37407420 |
| | Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma | Q37745101 |
| | European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? | Q37792645 |
| | Early progress in epigenetic regulation of endothelin pathway genes | Q37973381 |
| | Bone cancer pain: causes, consequences, and therapeutic opportunities | Q38126710 |
| | Pain and nociception: mechanisms of cancer-induced bone pain | Q38209631 |
| | Cancer induced bone pain | Q38336942 |
| | Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer | Q38361625 |
| | Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer | Q38529787 |
| | Bone pain: current and future treatments. | Q38759480 |
| | Study of breakthrough cancer pain in an animal model induced by endothelin-1. | Q38797886 |
| | High-incidence spontaneous tumors in JF1/Ms mice: relevance of hypomorphic germline mutation and subsequent promoter methylation of Ednrb | Q39066757 |
| | Decitabine, independent of apoptosis, exerts its cytotoxic effects on cell growth in melanoma cells | Q39456914 |
| | P2X7 receptor-deficient mice are susceptible to bone cancer pain. | Q39544211 |
| | DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair | Q39674490 |
| | Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. | Q40009811 |
| | Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine. | Q40361515 |
| | Coordinate regulation of microenvironmental stimuli and role of methylation in bone metastasis from breast carcinoma | Q40415482 |
| | The control of pain in peripheral tissue by opioids. | Q40531445 |
| | New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade | Q40957581 |
| | Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate | Q41304383 |
| | Pain-induced analgesia mediated by mesolimbic reward circuits | Q41683720 |
| | The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma | Q42459032 |
| | The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells | Q43579789 |
| | Influence of sex differences on the progression of cancer-induced bone pain | Q44282139 |
| | Opioid receptors and endogenous opioids in diverse human and animal cancers | Q44342157 |
| | Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats | Q44345132 |
| | Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer | Q44539462 |
| | Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. | Q45309425 |
| | MethyLight | Q46394365 |
| | Acute stress contributes to individual differences in pain and pain-related brain activity in healthy and chronic pain patients. | Q46757999 |
| | Spontaneous pain-like behaviors are more sensitive to morphine and buprenorphine than mechanically evoked behaviors in a rat model of acute postoperative pain. | Q46796521 |
| | Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States | Q47202399 |
| | Endothelin and the tumorigenic component of bone cancer pain | Q47320031 |
| | Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up | Q47594375 |
| | Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation | Q48014095 |
| | Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care | Q57689172 |
| | Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity | Q60681167 |
| | Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain | Q60745189 |
| | Analgesic effect of intraarticular morphine after arthroscopic knee surgery | Q68253539 |
| | Endothelin-1 participation in overt and inflammatory pain | Q69084409 |
| | Endothelins potentiate formalin-induced nociception and paw edema in mice | Q73640341 |
| | Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner | Q74661539 |
| | Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma | Q80163328 |
| | A role for endothelin in neuropathic pain after chronic constriction injury of the sciatic nerve | Q81511338 |
| | Endothelin: Ominous Player in Breast Cancer | Q94365440 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | bone cancer | Q18554919 |
| | cancer pain | Q3712728 |
| | murine model | Q122890741 |
| P304 | page(s) | 619-631 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Pain | Q2317902 |
| P1476 | title | Decitabine attenuates nociceptive behavior in a murine model of bone cancer pain | |
| P478 | volume | 160 | |